Mitozantrone-induced onycholysis. A series of five cases
| Autor: | Peter S. Mortimer, T.J. Powles, J.D. Creamer |
|---|---|
| Rok vydání: | 1995 |
| Předmět: |
medicine.medical_specialty
Pathology Antineoplastic Agents Breast Neoplasms Dermatology Foot Diseases Nail Diseases Carcinoma Medicine Humans Aged Cardiotoxicity Mitoxantrone business.industry Carcinoma Ductal Breast Onycholysis Middle Aged medicine.disease Lymphoma Nail disease Female business Breast carcinoma medicine.drug |
| Zdroj: | Clinical and experimental dermatology. 20(6) |
| ISSN: | 0307-6938 |
| Popis: | The anthracenedione cytotoxic agent, mitozantrone, has a well-established place in the treatment of acute leukaemia, lymphoma, breast carcinoma and other malignant tumours. In general it is well tolerated apart from myelosuppression and dose-related cardiotoxicity. Alopecia is a common side-effect with mitozantrone but otherwise the skin and its appendages are rarely affected. We present five cases of mitozantrone-induced onycholysis. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text